Navigation Links
Matthias Spaenle, MD, Joins Oppenheimer's Investment Banking Group as Managing Director - Healthcare
Date:5/18/2011

NEW YORK, May 18, 2011 /PRNewswire/ -- Oppenheimer & Co. Inc., a unit of Oppenheimer Holdings, is pleased to announce that Matthias Spaenle, MD will join the firm as Managing Director in the Healthcare group of the Firm's Investment Bank, where he will help to drive its life science business. He will report to Brian McCarthy, Managing Director and Head of Healthcare Investment Banking.  

Since 2003, Matthias had worked at JMP Securities, where he was a Senior Calling Officer in the Healthcare Group and had focused on biotechnology. Prior to working at JMP, he had worked for Robertson Stephens. A graduate of the Ross School of Business, the University of Michigan, Matthias initially trained in general surgery at the University Hospital Cologne in Cologne, Germany.

"Matthias is an experienced and highly regarded senior banker in the life science space. We are delighted that he's joining our healthcare investment banking team," Mr. McCarthy concluded.

Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), provides a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions.

Certain statements in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, as discussed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Oppenheimer & Co. Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
2. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
3. GM Exec Joins Bio-Reaction Industries Board of Directors
4. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
5. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
6. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
7. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
8. Charles C. Harwood, Jr., Joins Cellectar, Inc.s Board of Directors
9. Chief Technology Officer Joins ACAMP
10. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
11. Food and Beverage Giant Joins Kannapolis Research Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 2016 The U.S. Biotechnology industry ... billion of revenue and some $890 billion of total ... global biopharmaceuticals, and this figure is expected to exceed ... up these four equities for assessment: Northwest Biotherapeutics Inc. ... ACAD ), Acorda Therapeutics Inc. (NASDAQ: ...
(Date:12/4/2016)... -- In five studies being presented today during the 58th ... in San Diego , researchers are ... of life-saving treatments to patients with a variety of ... therapies directly to the sites in the body where ... advantage over traditional, systemic methods. The studies highlight the ...
(Date:12/2/2016)... , Dec. 2, 2016 More than $4.3 million ... Helix Medals dinner ( DHMD ). The gala was held at ... New York City and honored Alan Alda ... respectively, to health and medicine and the public understanding of ... in 2006, the event has raised $40 million for the ...
(Date:12/2/2016)... -- CytRx Corporation (NASDAQ: CYTR ), a ... announced the appointment of Earl Warren Brien , ... healthcare investor, to its Board of Directors. ... strategic experience at the highest level," said Steven ... of the world,s leading orthopedic surgeons, Dr. Brien has ...
Breaking Biology Technology:
(Date:11/22/2016)... , November 22, 2016 According to the ... IRIS, Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), ... published by MarketsandMarkets, the market is expected to grow from USD 10.74 ... CAGR of 16.79% between 2016 and 2022. ... ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... , Nov 15, 2016 Research and Markets ... Forecast to 2021" report to their offering. ... ... 16.18 Billion by 2021 from USD 6.21 Billion in 2016, growing ... Growth of the bioinformatics market is driven by the growing ...
Breaking Biology News(10 mins):